CollPlant Biotechnologies Provides a Corporate Update

- Additional patent granted for photocurable dermal filler - Update on AbbVie dermal filler program and achievement of contingent payment - Plan for cost reductions in place to extend cash runway REHOVOT, Israel, Feb. 12, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), or...